Therapy at the intracellular level to replace or inactivate the effects of disease-causing genes or to augment normal gene functions to overcome illness.
Recently, the Centers for Disease Control and Prevention announced suicide rates in the U.S. increased by 25 percent over the last two decades, and more than half of those who died by the disease had not been diagnosed with a mental health condition.
From advanced biologics to transformative therapies, such as cell and gene therapy, recent advancements have revolutionized our ability to treat, and in some cases cure, some of the most challenging diseases.
Since peaking in 1991, the death rate associated with cancer declined by 29%, which translates to 2.9 million fewer cancer deaths.
As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines like targeted treatments that could transform the lives of patients living with the disease.